Список проголосовавших за комментарий " Notable movers of interest: UAA -24% on Q4 EPS and revenue miss, guidance<p>The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).</p><p><strong>Large Cap Gainers</strong></p><ul><li><strong>S</strong> (9.55 +4.83%): Shares rise on Q3 revenue beat; sees FY17 profit at the high end of prior range.</li><li><strong>TMO</strong> (149.49 +4.32%): Reports Q4 EPS beat; guides FY17 adj. EPS and revenues above consensus.</li><li><strong>ABC</strong> (86.9 +3.92%): Reports Q1 EPS beat; raises FY17 EPS guidance.</li></ul><p><strong>Large Cap Losers</strong></p><ul><li><strong>UAA</strong> (21.98 -24.05%): Shares fall on Q4 EPS and revenue misses; guides FY17 revs below consensus; CFO departing.</li><li><strong>UPS</strong> (110.31 -5.74%): Reports Q4 EPS miss; guides FY17 EPS below consensus.</li><li><strong>HOG</strong> (55.65 -3.92%): Reports Q4 EPS and revenue misses; sees FY17 shipments flat to down modestly with gross margin flat.</li></ul><p><strong>Mid Cap Gainers</strong></p><ul><li><strong>NTCT</strong> (33.38 +6.12%): Reports Q3 EPS beat.</li><li><strong>ALLY</strong> (20.71 +5.18%): Shares rise on Q4 EPS and revenue beats.</li><li><strong>BLUE</strong> (71.75 +4.59%): President Trump after meeting with pharma execs repeats that drug industry needs to get prices down related to medicare/medicaid; says he wants to speed up FDA approval process (<strong>CELG</strong>, <strong>AMGN</strong>, <strong>NVS</strong>...).</li></ul><p><strong>Mid Cap Losers</strong></p><ul><li><strong>CNX</strong> (16.52 -9.73%): Reports Q4 revenue miss.</li><li><strong>CR</strong> (68.84 -6.85%): Shares fall despite a Q4 EPS and revenue beat; guides FY17 revenues below consensus; extends asbestos liability estimate through 2059.</li><li><strong>XRX</strong> (6.7 -3.67%): Reports Q4 revenue miss; guides FY17 EPS in-line.</li></ul>"